Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant human thrombopoietin (rhTPO)

recombinant human thrombopoietin
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Recombinant human thrombopoietin (rhTPO), covering 2016-04-20 to 2018-04-10. Get the full timeline:

Most recent: Clinical Trial Update: Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune Thrombocytopenia [Phase 3]

See pricing